Focal adhesion kinase
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
<StructureSection load='2jkk' size='350' side='right' scene='48/480805/Cv/1' caption='Focal adhesion kinase 1 kinase domain complex with pyrimidine derivative inhibitor and sulfate (PDB code [[2jkk]]) '> | <StructureSection load='2jkk' size='350' side='right' scene='48/480805/Cv/1' caption='Focal adhesion kinase 1 kinase domain complex with pyrimidine derivative inhibitor and sulfate (PDB code [[2jkk]]) '> | ||
| + | == Function == | ||
| - | For details on '''focal adhesion kinase or protein tyrosine kinase 2β (PTK2)''' see [[Molecular Playground/FAK]]<ref>PMID:15688067</ref>. | + | '''Focal adhesion kinase''' (FAK) is involved in cellular adhesion. During apoptosis, FAK is cleaved into 2 fragments. The smaller fragment is associated with death signaling. For details on '''focal adhesion kinase or protein tyrosine kinase 2β (PTK2)''' see [[Molecular Playground/FAK]]<ref>PMID:15688067</ref>. |
== Relevance == | == Relevance == | ||
Revision as of 08:57, 27 January 2016
| |||||||||||
3D Structures of focal adhesion kinase
Updated on 27-January-2016
References
- ↑ Mitra SK, Hanson DA, Schlaepfer DD. Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol. 2005 Jan;6(1):56-68. PMID:15688067 doi:http://dx.doi.org/10.1038/nrm1549
- ↑ Cabrita MA, Jones LM, Quizi JL, Sabourin LA, McKay BC, Addison CL. Focal adhesion kinase inhibitors are potent anti-angiogenic agents. Mol Oncol. 2011 Dec;5(6):517-26. doi: 10.1016/j.molonc.2011.10.004. Epub 2011 Oct, 20. PMID:22075057 doi:http://dx.doi.org/10.1016/j.molonc.2011.10.004
- ↑ Lietha D, Eck MJ. Crystal structures of the FAK kinase in complex with TAE226 and related bis-anilino pyrimidine inhibitors reveal a helical DFG conformation. PLoS ONE. 2008;3(11):e3800. Epub 2008 Nov 24. PMID:19030106 doi:10.1371/journal.pone.0003800
